Findings from studies investigating the efficacy and safety of corneal collagen crosslinking (CXL) for keratoconus in paediatric-age patients and developmentally delayed adults and the consequences of leaving their ocular disease untreate
Cheryl Guttman Krader, BS, Pharm
This article was reviewed by Donald Tran, MD
An abundance of evidence from randomised, controlled clinical trials supports the use of topical atropine to prevent myopia progression.
This article was reviewed by Burkhard Dick, MD
This article was reviewed by Guyléne Le Meur, MD